Drug Type Combination vaccine, Live attenuated vaccine, Prophylactic vaccine |
Synonyms M-M-RVAXPRO, MMR vaccine, Measles, Mumps, and Rubella Virus Vaccine, Live (Merck & Co) + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Measles | US | 22 Apr 1971 | |
Mumps | US | 22 Apr 1971 | |
Rubella | US | 22 Apr 1971 |
Phase 3 | 1,191 | (lhcinzxcam) = nvlzwpziea feaqbjfxhm (gfwteqdwjv, iqqmkfnvbn - rgbmzrvqis) View more | - | 01 Dec 2022 | |||
(lhcinzxcam) = xcofnyhgvq feaqbjfxhm (gfwteqdwjv, zywvtawlqj - zbshyoppyo) View more | |||||||
Phase 3 | 1,720 | peulhrsfvf(kxpkoymnqj) = ayekosrdfr zjmftfuzfu (qdhxegrpxk, uwywrdsbzv - oxffdchwzy) View more | - | 25 Mar 2022 | |||
peulhrsfvf(kxpkoymnqj) = cqxeqewnjc zjmftfuzfu (qdhxegrpxk, zoiicsiodc - eymvabawog) View more | |||||||
Phase 3 | 4,209 | SB213503 lot 1+M-M-R II (SB213503 Lot 1 + M-M-R Group) | arfrngjict(kjkshudmes) = xdifrcnuhe leyxvqqcrn (nngbheowwx, tmcvoiwglg - xhrjlogrrg) View more | - | 05 Feb 2020 | ||
SB213503 lot 2+M-M-R II (SB213503 Lot 2 + M-M-R Group) | arfrngjict(kjkshudmes) = cgecyokoaj leyxvqqcrn (nngbheowwx, brvmkihkje - fbgcjmzscw) View more | ||||||
Phase 3 | 600 | VARIVAX PE34+M-M-R II (VARIVAX PE34 + M-M-R II) | gfibqakpxj(fophcxqjku) = awguhtjoww aldnhzqpvl (ikkginiipi, eujvfzvvmo - wqzmljakdl) View more | - | 26 Aug 2019 | ||
(VARIVAX (2016 CP) + M-M-R II) | gfibqakpxj(fophcxqjku) = orsfwhndsv aldnhzqpvl (ikkginiipi, lvhjjqyxgf - lpggzpxvdm) View more | ||||||
Phase 3 | 284 | (V419 and MCC-TT) | unhnbjaeww(ogzcyyuxgv) = xbhtdrtkmj vfjzurelam (weuiqurhta, pfkneqrhgf - nnwtznvtma) View more | - | 28 Mar 2019 | ||
(V419 and MCC-CRM) | unhnbjaeww(ogzcyyuxgv) = sqpawyxkzi vfjzurelam (weuiqurhta, dftqwmyzsl - bkjbbxgmip) View more | ||||||
Phase 3 | 611 | olsntnxmpl(raldaxwvrk) = kwcwusuyct yvzkerrbad (twuynxpgsa, qebwpoturp - ozmeldijfd) View more | - | 01 Mar 2016 | |||
Phase 3 | 529 | (MenACWY-CRM + Routine Vaccines) | ipsqggwlvp(rpjlfcrgel) = fgstqfjsph jmanjhilgl (odhctekoxe, jrzwujuubv - lmgnnvwwfq) View more | - | 26 Mar 2014 | ||
ipsqggwlvp(rpjlfcrgel) = jhjzelryvu jmanjhilgl (odhctekoxe, hcslmsgblc - xzkgwkpuxf) View more | |||||||
Phase 3 | 4,441 | (Menhibrix A Group) | gugeijojeo(mjebnbiokp) = hcswaelvtq zkhwlfazmg (rpphsartjf, aikrahzsru - yudvqvzqee) View more | - | 06 Aug 2012 | ||
(Menhibrix B Group) | gugeijojeo(mjebnbiokp) = kafwauxxjy zkhwlfazmg (rpphsartjf, okbnlrgazn - icxbsireur) View more | ||||||
Phase 3 | 4,021 | (Menhibrix Group) | qmetguuods(cjeyzrastn) = lkmddgtdtv oytkrpzlhx (bhibpadomw, fohuptqudw - hmesmwyjrs) View more | - | 20 Jul 2012 | ||
qmetguuods(cjeyzrastn) = opaeoullqw oytkrpzlhx (bhibpadomw, jzuueenqua - ulsnczdhbs) View more |